For each year of the Track Record Period, our impairment losses on financial assets were RMB76.7 million, RMB25.4 million, and RMB9.0 million, respectively.
Financial Information · 第 356 页
In February 2023, we initiated proceedings against the acquiror in Haicang District People's Court in Xiamen for such last installment payment, and received a judgment in our favor in May 2023.
Financial Information · 第 357 页
As of the Latest Practicable Date, we do not have any business relationships with the acquiror and Relevant Receivable had been fully impaired.
As a result, our direct equity interest in Shanghai Regenelead was diluted from 100% to approximately 38%, and a deemed disposal gain of RMB291.1 million was recorded as the excess of fair value of our retained equity interest in Shanghai Regenelead over the carrying amount of Shanghai Regenelead's net assets at the deemed disposal date when we lost control of Shanghai Regenelead.
Financial Information · 第 364 页
Our other income and gains decreased by 24.6% from RMB1,371.2 million in 2022 to RMB1,033.8 million in 2023, primarily because (i) we had an RMB326.0 million in gain on deemed disposal of subsidiaries in 2022, while we did not have this item in 2023, and (ii) our gain on financial assets at FVTPL decreased by RMB202.6 million, primarily because we recognized a significant gain on fair value changes of our investment in an unlisted entity and wealth management products in 2022.
In 2023, we recorded net foreign exchange loss of US$1.3 million, which was primarily due to unrealized exchange loss derived from revaluation of accounts receivables.
Financial Information · 第 519 页
We recorded a net foreign exchange loss of US$3.7 million in 2024.
Financial Information · 第 519 页
This change was due to (i) an increase in net foreign exchange loss of US$2.5 million, and (ii) an increase of US$2.9 million in impairment of goodwill due to Jianian and Prime Heart in light of uncertainty of business plan.
Other net income/(losses) primarily consisted of (i) restoration costs incurred when we close certain restaurants and terminate relevant lease agreements with lessors and the compensation received from landlords for the restaurants we closed due to breach of contract on the part of the relevant landlords, (ii) rent concessions granted by lessors due to the COVID-19 pandemic, (iii) net foreign exchange income/(losses), (iv) loss on disposal of assets, and (v) other income/(losses), primarily relating to inventory write-down.
Our other income and gains, net increased from RMB27.0 million in 2022 to RMB66.6 million in 2023, primarily due to an increase in our government grants from RMB24.1 million in 2022 to RMB54.3 million in 2023 which was attributable our business growth.
Summary · 第 15 页
(i) part of the government grants received in 2023 was not recurring in nature. For example, the government grants for a industrial technology upgrading project we received in 2023 were not recurring in 2024; and (ii) the time of receiving such subsidies is usually uncertain, resulting in fluctuations in the amounts.
Financial Information · 第 260 页
Our other income and gains, net decreased by 27.7% from RMB66.6 million in 2023 to RMB48.1 million in 2024, primarily due to a decrease in government grants of RMB30.1 million as more government grants were received in 2023, which was partially offset by an increase in fair value changes of financial assets and financial investments at fair value through profit or loss of RMB8.9 million mainly attributable to an increase in our wealth management products.
海南钧达新能源科技股份有限公司Hainan Drinda New Energy Technology Co., Ltd.02865.HK
政府补助大幅增长并支持2024年毛利转正
In 2022, 2023 and 2024, we had RMB13.1 million, RMB336.3 million and RMB816.9 million directly recognized in profit or loss, respectively.
Summary · 第 6 页
The government grants of RMB9.8 million, RMB283.3 million and RMB746.6 million related to subsidies for utilities, equipment and employment were deducted from cost of sales in 2022, 2023 and 2024, respectively.
Financial Information · 第 391 页
In the fourth quarter of 2024 and the first quarter of 2025, we returned to and maintained a gross profit position due to the recovery in the average selling price of PV cells attributable to supply-demand adjustment in the industry, our improvement in production efficiency and factoring in government grant.
Our other net gain significantly increased from RMB4.5 million in 2023 to RMB24.6 million in 2024, primarily attributable to the recognition of gain on disposal or loss of significant influence of associates of RMB16.3 million in 2024, resulting from the reclassification of our interest in one associate to other investments based on the assessment that we no longer have significant influence on that associate following its recent equity financing and the resignation of our board representative.
Financial Information · 第 324 页
We recorded other net gain of RMB121 thousand, RMB4.5 million and RMB24.6 million in 2022, 2023 and 2024, respectively.
We recorded net other gains of RMB40.8 million in 2023, which decreased to RMB14.4 million in 2024, primarily due to the exchange rate fluctuations between U.S. dollar and Renminbi.
Financial Information · 第 454 页
During the Track Record Period, our net other gains primarily consisted of net foreign exchange gains, as a result of fluctuations in currency exchange.
南山铝业国际控股有限公司Nanshan Aluminium International Holdings Limited02610.HK
9M2024录得660万美元净汇兑损失
The decrease was mainly due to the foreign exchange loss of US$6.6 million recognised by our Group for 9M2024, whereas a foreign exchange gain of US$3.8 million was recorded by our Group for 9M2023.
Financial Information · 第 340 页
(2) Such forward exchange contracts were entered into by our Group for fixing the exchange rate between USD and IDR.
Loss from discontinued procurement contract related to our cancellation of the commitment to purchase the previously reserved drug substance under a commitment and pre-payment agreement with Ascendis Pharma.
Financial Information · 第 433 页
We recorded net gains of RMB77.2 million in 2022, and recorded net losses of RMB106.7 million in 2023.
Financial Information · 第 439 页
Our net other losses decreased from RMB102.4 million for the nine months ended September 30, 2023 to RMB0.4 million for the nine months ended September 30, 2024, primarily due to the loss from a discontinued procurement contract recorded in the amount of RMB109.0 million in the nine months ended September 30, 2023 in relation to our cancellation of the commitment to purchase the previously reserved drug substance under the commitment and pre-payment agreement in February 2023
Our other income and gains increased significantly by 200.2% from RMB90.6 million for the nine months ended September 30, 2023 to RMB272.0 million for the nine months ended September 30, 2024. This was primarily due to: (i) an increase in gains on disposal of derivative financial instruments of RMB108.5 million; and (ii) an increase in gains on disposal of investment in an associate of RMB71.1 million.
Financial Information · 第 503 页
This was primarily because Jilong Mining conducted hedging business for gold leasing, purchased gold futures contracts, and recorded an investment income of RMB143.4 million from disposal of hedging instruments in 2024.
For the six months ended June 30, 2023 and 2024, we recorded other income of RMB7.7 million and other loss of RMB2.7 million, respectively.
Financial Information · 第 321 页
Our foreign exchange gains/(loss) derive from the sales of RVs by our operating entities in the PRC primarily conducted in Australian dollars in the ordinary and usual course of our business.
Financial Information · 第 322 页
The change was primarily due to the transition from foreign exchange gain of RMB7.8 million for the six months ended June 30, 2023 to foreign exchange loss of RMB2.5 million for the six months ended June 30, 2024, driven by the overall weakening of the Australian dollar relative to the Renminbi in the latter period.
Since the overall lease term was shortened from ten years to six years, we recognized a lease modification of RMB6.7 million in 2021.
Financial Information · 第 322 页
Our other income increased by RMB1.0 million, or 12.4%, from RMB8.1 million in 2021 to RMB9.1 million in 2022, primarily due to (i) an increase in foreign exchange gain of RMB7.4 million, and (ii) an increase in government grants of RMB0.5 million in 2022; partially offset by a lease modification of RMB6.7 million we incurred in 2021.
Our other income decreased by approximately RMB7.3 million (or approximately 35.2%) from approximately RMB20.8 million for 6M2023 to approximately RMB13.5 million for 6M2024, which was primarily attributable to (i) the decrease in our government grants from approximately RMB12.5 million for 6M2023 to approximately RMB10.3 million for 6M2024 mainly because of the decrease in government grants under Government Contract 3 and Government Contract 9 by approximately RMB6.8 million, partially offset by the increase in government grants under Government Contract 8 and Government Contract 10 by approximately RMB5.1 million; and (ii) the decrease in VAT refund from approximately RMB7.9 million for 6M2023 to approximately RMB1.6 million for 6M2024 mainly because the sales of our software products which were regarded as qualified proprietary software sales according to the relevant tax policy decreased in 6M2024 as compared to that in 6M2023.
纽曼思健康食品控股有限公司Numans Health Food Holdings Company Limited02530.HK
奶粉业务一次性亏损拨备及递延税项收益
The significant decrease in effective tax rate from approximately 22.4% for FY2021 to approximately 11.1% for FY2022 was mainly driven by the deferred tax income primarily related to the losses relating to milk powder products of approximately RMB21.2 million for FY2022 as disclosed above.
Financial Information · 第 362 页
As at 31 December 2022, we recognised loss allowances of approximately RMB20.1 million in respect of our deposits paid to Ausnutria Group.
Financial Information · 第 381 页
As at 31 December 2022, 31 December 2023 and 30 June 2024, the milk powder products in our inventories had been fully written off/provided for.
脑动极光医疗科技有限公司BrainAurora Medical Technology Limited06681.HK
2022年一次性费率追溯调整压低毛利率
The decrease in our gross profit margin from 2021 to 2022 was primarily due to an one-time retrospective fee rate adjustment with respect to a service provider in September 2022 from floating rates (based on sales volume) to a fixed rate at the high end of the previously floating rate range, which contributed to the higher fee rate and the resulting lower gross profit margin in 2022.
Summary · 第 25 页
The increase in our gross profit margin from 2022 to 2023 was primarily because the above-mentioned retrospective fee rate adjustment for periods prior to 2022 was all recorded in 2022 resulting in lower gross profit margin in 2022.
Our other net income increased by 9.5% from RMB7.4 million in 2021 to RMB8.1 million in 2022, which was primarily attributable to the increase of RMB9.4 million in net gain on disposal of subsidiaries, partially offset by (i) net foreign exchange loss; and (ii) net loss on sale of property, plant and equipment.
Financial Information · 第 460 页
Our other net income decreased from RMB8.1 million in 2022 to RMB3.9 million in 2023, primarily due to the one-off net gain on disposal of subsidiaries recorded in 2022, partially offset by the decrease in net foreign exchange loss.
Our other income, primarily consisting of government grants, was RMB23.9 million, RMB4.7 million, RMB27.9 million, RMB3.2 million and RMB6.3 million in 2021, 2022 and 2023 and the six months ended June 30, 2023 and 2024, respectively.
Financial Information · 第 392 页
Our other income decreased by 80.2% from RMB23.9 million in 2021 to RMB4.7 million 2022, primarily due to our receipt of a one-off financial subsidy for new resident enterprises from the local government and VAT tax rebate in 2021.
Financial Information · 第 402 页
The increase in our adjusted net loss (non-IFRS measure) in 2022 was mainly due to: (i) an increase in our research and development expenses, mainly arising from an increase in our employee benefit expenses as a result of the expansion of our R&D team; and (ii) a decrease in our other income, due to fluctuations in the one-off financial subsidies from the local government that we received, which was partially offset by a significant increase in our gross profit.
We had a gain from disposal of RMB100.1 million relating to the disposal of DFI Digital (Hong Kong) Limited and DFI Digital (Singapore) PTE. Limited in April 2022, which contributed to decreasing our net loss in 2022.
Summary · 第 12 页
The disposal was based on the Group’s overall strategic considerations to focus on our core business as a one-stop digitalization solutions provider, enhance Retail Technology Asia’s service capabilities to facilitate our global expansion and build a more sustainable business model for strong and visible growth.
In the meantime, the unrealized profit from intergroup transactions was realized as disposal gain, which was included in the results of discontinued operations.
Financial Information · 第 389 页
(iii) depreciation on property and equipment of RMB19.4 million partially offset by gain on disposal of subsidiaries of RMB253.9 million.